i hope so... my bet to stand above RM21

got it, thanks @Johnng8882020

https://www.theedgemarkets.com/article/hartalega-overtakes-public-bank-malaysias-third-most-valuable-listed-firm

Hartalega overtakes Public Bank as Malaysia’s third most valuable listed firm

seems it will take a little bit more time, but breaking RM1 is a matter of when aje...

ya the gloves stock is really too high... can't find a place there... i'm trying my luck with this Esceram & Notion Vtec... looks possible to break RM1...

vaccines on HUMAN CLINICAL TRIAL... there are more than 10 countries doing HCT by today... The risk is HIGH...

personally i think those who already been infected will accept the HCT as no other choice

Notion VTec said it will make further announcements whenever there is any material development on its healthcare-related business activities.

it worth >1.00

@limkokthye read the article and put a proper title lar... planning to ‘register’ its novel Coronavirus vaccine by August 10-12... again PLANNING...

@limkokthye read the article and put a proper title lar... planning to ‘register’ its novel Coronavirus vaccine by August 10-12... again PLANNING...

who is going to approve if the responsibility is on the Approval... i can only take 1 person for that... Trump you are the man for this

who is going to approve if the responsibility is on the Approval... i can only take 1 person for that... Trump you are the man for this

who is going to approve if the responsibility is on the Approval... i can only take 1 person for that... Trump you are the man for this

planning to ‘register’ its novel Coronavirus vaccine by August 10-12... again PLANNING... they can do whatever they want with their own people...

looks like another putih2 mati sardines run... sharks eats all, aduiii

looks like another putih2 mati sardines run... sharks eats all, aduiii

looks like another putih2 mati sardines run... sharks eats all, aduiii

is it safe to enter below 0.80c

19.20 i think i know who is sorchai... @TeamRocket kakakaka~

https://www.theedgemarkets.com/article/hlt-global-says-not-selling-gloves-online-seeking-legal-advice-course-action

me too stay low profile...

ask the NZ to buy 10 dom2 put 10 fingers... buat kecoh aje~

ask the NZ to buy 10 dom2 put 10 fingers... buat kecoh aje~

kutip sampai no cash jor... cizzz

kutip sampai no cash jor... cizzz

i avoid warrant... very scary...

driving without tyres... hospitals will shutdown without gloves...

took my profit, thanks Harta, I will be back... :D

i juz copy & paste, dun ask me as i'm dum2 with this report

Steep ASP hikes ahead!

Laggard in share price; maintain BUY
Kossan is our top pick: (i) Stock is a laggard with its share price only
gaining 245% YTD (Top Glove: +470% YTD); (ii) ASPs will be raised
aggressively in the coming months, potentially matching that of Top
Glove. We maintain our FY22E EPS but raised our FY20-21E EPS by
48%/201% on higher ASP assumptions. Our new TP is MYR19.50 (+78%) on
a lower FY21E P/E of 16x (from 27x previously; 5-year mean: 18x).
Kossan could be included in the FBM KLCI in the upcoming review in Nov.

Will match market’s ASPs
Kossan has secured orders until Jun 2021 and is taking orders for 2H21.
Its blended ASP (including spot) is also on an uptrend (2Q20: +5% QoQ)
and its ASP hikes are more aggressive in Jul-Aug (Jul: +20% vs. 2Q20, Aug:
+40% vs. 2Q20). We think its ASP hikes will remain aggressive in the
coming months as it tries to catch up with the market’s ASPs. Spot
currently accounts for 10% of its volume and it could be raised to 15%. Its
spot ASPs is USD60-85/k pieces now (+2-3x of the normal ASPs).

Moderate capacity growth in FY20-21E
Plant 19 (3b pcs p.a.) will be fully-commercialised by Aug 2020 (+10% to
32b pcs p.a.). For FY21-22, Kossan has lined up the following expansion:
(i) Plant 20 (Klang) – To commercialise in 1H21 with a capacity of 1.4b
pcs p.a.; (ii) Plant 21 (Phase 1, Klang) – To commercialise in 2H21 with a
capacity of 2b pcs p.a.; (iii) Plant 21 (Phase 2, Klang) – To commercialise
in 1H22 with a capacity of 3b pcs p.a.; (iv) Plant 22 (Bidor) – To
commercialise in 2H22 with a capacity of 4b pcs p.a. We estimate that
its effective capacity will grow 13%/7%/17% in FY20-22E.

Raise FY20-21E earnings forecasts
With the industry players matching Top Glove’s high ASPs, we think the
ASPs could sustain at the high levels in 1Q21 and potentially trend lower
gradually from 2Q21 as the new supply alleviate the acute shortage. We
raise our ASP by 38%/132%/37% for FY20-22E and also raise our NBR cost
by 35%/89%/89%. Our FY20-21E EPS is raised by 48%/201% while our
FY22E EPS is unchanged as the higher costs offset the higher ASP.

Totally no idea WTHell happened :D

oic thanks @yttihs

if i buy back, counted as kontra or will i entitle for the bonus... walao~ headache liao~

but i juz sold out this morning, should i buy back? anyone can answer?

normally 16:30 will see sharks coming from noway...

i hugging TG, Harta, K+ everynight

rite, i saw Comfort, Kossan, Carepls all rocket high today

something going to happen??? any idea ?

i'm holding mine...

instead of using animals, they started to use human as trial...

hope for the best tomorrow...

i'm so lucky to catch the boat yesterday @2.49

i also feel the same @Keng592

me too enter @0.38

i juz mention Pharma & Dpharma aje, oledi start sardines run, escape or being trap...

my guess Pharma & Dpharma politik related, i only see people's handing $ to them.

today i tell u all that i will going to sell a product,
galantee every1 will need 2 of these,
but now i need build factories first,
after factories build, then we wait for the product...

sounds like a scam... kakakaka~ gonna be panic sell soon...

may i ask, even if the vaccine is available, how do Malaysia produce them? I thought who found it will profit from it...

ok ok ... waiting...

show started

@chopstick there is no "us" here, only u. Everyone know gloves is not the solution to the Covid-19.
You are the only one which doesn't have common sense...

then go Pharmaniaga / Duopharma , buy and wait there, go tokok there, why here?